ClinicalTrials.gg
CompletedNCT04524013Updated Nov 22, 2023

Swiss National Iodine Survey 2020

An observational study in Healthy, sponsored by Isabelle Herter-Aeberli. Completed at 1 site in Switzerland. Open to participants aged 6 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-22.

Sponsored by Isabelle Herter-Aeberli · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
875
Ages
6 Years to 44 Years
Sex
All
01

Study summary

This study will assess iodine status in school aged children and pregnant women is Switzerland. In addition, thyroid status and omega-3 index will be assessed in pregnant women.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Isabelle Herter-Aeberli is the lead sponsor of 13 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 44 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Both groups: nationally representative sample selected through schools (children) and gynecologists (women).

School aged children: aged between 6 and 12 years Pregnant women: aged between 18 and 44 years, pregnant

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy
  • for pregnant women: confirmed pregnancy
  • living in Switzerland for min 1 year

Exclusion criteria

Exclusion Criteria:

  • no history of major medical illness
  • no iodine containing contrast agents or medication in the past 6 months
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
875 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • School aged children

    Other: There is no intervention. It is an observational study.

  • Pregnant women

    Other: There is no intervention. It is an observational study.

Interventions

  • OtherThere is no intervention. It is an observational study.

    There is not intervention

06

What researchers measure

Primary outcomes

  1. Urinary iodine concentration

    urinary iodine concentration in spot urine samples

    Time frame: Baseline

Secondary outcomes

  1. Urinary creatinine concentration

    Urinary creatinine concentration in spot urine samples

    Time frame: Baseline

  2. Urinary sodium concentration

    Urinary sodium concentration in spot urine samples

    Time frame: Baseline

  3. Urinary fluoride concentration

    Urinary fluoride concentration in spot urine samples

    Time frame: Baseline

  4. Thyroid stimulating hormone

    TSH from dried blood spots

    Time frame: Baseline

  5. T3

    T3 from dried blood spots

    Time frame: Baseline

  6. T4

    T4 from dried blood spots

    Time frame: Baseline

  7. Omega 3 index

    Omega 3 index from dried blood spots

    Time frame: Baseline

Other outcomes

  1. Weight

    Time frame: Baseline

  2. Height

    Time frame: Baseline

  3. Omega 3 intake

    Assessment of omega 3 intake using a food frequency questionnaire

    Time frame: Baseline

  4. Depressive symptoms

    Assessment of depressive symptoms using the Edinburgh Postnatal Depression Scale (EPDS).

    Time frame: Baseline

07

Study locations

1 site
  • Human Nutrition Laboratory, ETH Zurich
    Zurich, 8092, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04524013
Lead sponsor
Isabelle Herter-Aeberli
Collaborators
Department of Epidemiology and Health Services, Unisanté, Lausanne, University Children's Hospital, Zurich
Responsible party
Isabelle Herter-Aeberli (Senior Scientist, PhD, Swiss Federal Institute of Technology) — Sponsor-investigator
First posted
Aug 24, 2020
Start date
Oct 1, 2020
Primary completion
Aug 31, 2022
Completion
Jul 30, 2023
Last update
Nov 22, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion